Kenneth O'Keefe - Aug 2, 2024 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
By: /s/Adam Guttmann, as attorney in fact For: Kenneth O'Keefe
Stock symbol
JAZZ
Transactions as of
Aug 2, 2024
Transactions value $
-$165,243
Form type
4
Date filed
8/6/2024, 06:40 PM
Previous filing
Aug 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +3.73K +15.09% $0.00 28.5K Aug 2, 2024 Direct F1
transaction JAZZ Ordinary Shares Tax liability -$165K -1.48K -5.22% $111.35 27K Aug 6, 2024 Direct F2
holding JAZZ Ordinary Shares 4.45K Aug 2, 2024 by Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 25, 2025.
F2 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F3 Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.